Maintenance Treatment for Abstinent Smokers

• Status: Completed
• Trial end date: 2006-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the efficacy and cost-effectiveness of long-term pharmacotherapy (using Zyban and/or nicotine replacement) for reducing the relapse rate associated with stopping smoking.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: National Institute on Drug Abuse (NIDA)
• Collaborator: Research Foundation for Mental Hygiene, Inc.
• Treatments: Bupropion; Nicotine

Criteria

Inclusion Criteria:

• Patients who smoke at least 10 cigarettes daily and have attempted to quit smoking at least once

Exclusion Criteria:

• Seizure History

• Unstable Blood Pressure

• Current major depression

• Current alcohol/drug abuse or dependency

• Lifetime psychotic illness

• Current use of psychotropic drugs

• Unstable medical condition